Article Details

Swedish Biotech Oasmia Settles Investor Claims For $2.4M

Retrieved on: 2021-01-07 23:03:45

Tags for this article:

Click the tags to see associated articles and topics

Swedish Biotech Oasmia Settles Investor Claims For $2.4M. View article details on hiswai:

Excerpt

The cancer biotechnology firm's American Depositary Shares are publicly traded in the U.S. on the Nasdaq capital market. The suit alleges that all the ...

Article found on: www.law360.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up